Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,180.6
38.9 (1.24%)

 

  • STI Straits Times Index
    3,180.6
    38.9 (1.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.9
    -2.5 (-0.16%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,315.3
    841.4 (3.30%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,411.7
    50.1 (1.49%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,782.4
    200.8 (0.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,120.7
    32.2 (0.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,159.2M
  • Value: 1,470.4M
  • Rise: 205
  • Fall: 137
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
GKE0.153-0.008
Golden Agri-Res0.235+0.020
CapAllianz0.003-
Abundance Intl0.042-
Singtel2.280+0.050
Shen Yao0.007+0.001
RH PetroGas0.182+0.010
ISDN0.780+0.070
Sembcorp Marine0.108-0.002
Geo Energy Res0.260+0.015

World Indices

World Indices
Name Last Change
Nasdaq 14,762.6 +102.0
HSI 26,315.3 +841.4
HSCEI 9,415.7 +344.6
Jakarta 6,120.7 +32.2
Nikkei 225 27,782.4 +200.8
SSE Comp 3,411.7 +50.1
Shanghai A 3,575.8 +52.6
Shanghai B 256.1 +1.6
KOSPI 3,242.7 +5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GLAUKOS CORPORATION GLAUKOS CORP
Updated on 28 Jul 2021 (End of trading day)
Last (USD): 49.160 Change: +0.960 High: 49.760 Remarks: -
Change (%): +1.99 Low: 48.510
Open 48.720 Yesterday's Close 48.199999999999996
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 756,386 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.60034 Trailing EPS (USD) e -1.78816 NAV (USD) b 12.7432
PE a - Trailing PE f - Price / NAV b 3.8577
Dividend (USD) d - Cash In Hand (USD) g 2.0878 Issued & Paid-up Shares c 46,281,600
Dividend Yield (%) d - Price / Cash In Hand g 23.546 Treasury Shares h 28,000
Market Cap (M) 2,275.203 Enterprise Value (M) 2,230.338
Piotroski F Score 1 Exchange Code GKOS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 52.74 Free Float (%) 96.1
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 04 Sep 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GLAUKOS CORPORATION NYSE 2,275.203 - - 3.8577 -
Industry Medical Specialties NYSE 42,305.283 46.251 37.214 5.7588 0.609
Local Peer ABBOTT LABORATORIES NYSE 214,142.346 47.874 33.718 - 1.266
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 207,624.902 32.569 26.202 5.9223 0.168
Local Peer DANAHER CORP NYSE 209,087.032 59.569 59.569 5.2949 0.245
Local Peer MEDTRONIC PLC NYSE 175,405.828 48.643 48.643 3.4107 1.779
Local Peer STRYKER CORP NYSE 101,224.653 63.305 67.890 - 0.875
Local Peer BECTON DICKINSON & CO NYSE 73,716.800 96.111 44.949 2.9696 1.259
Local Peer EDWARDS LIFESCIENCES CORP NYSE 68,417.368 83.091 80.396 14.6868 -
Local Peer BOSTON SCIENTIFIC CORP NYSE 64,551.941 - 218.081 - -
Local Peer AGILENT TECHNOLOGIES INC NYSE 45,959.477 63.921 49.686 9.5550 0.480
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,741.654 30.848 31.159 2.9450 2.240
Local Peer BAXTER INTERNATIONAL INC NYSE 41,188.607 37.376 38.566 4.8732 1.171
Local Peer RESMED INC NYSE 38,712.154 62.271 84.665 14.2889 0.584
Other Local Peers ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 115,482.430 108.884 71.171 10.6558 -
Global Peer IDEXX LABORATORIES INC NASDAQ 59,319.549 101.963 87.984 84.4171 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 49,212.677 27.712 107.420 14.5017 -
Global Peer DEXCOM INC NASDAQ 44,476.978 90.107 86.531 23.3696 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 29,380.176 40.379 34.460 9.2518 -
Global Peer NOVOCURE LTD NASDAQ 18,812.893 949.776 1,604.101 50.5544 -
Global Peer HOLOGIC INC NASDAQ 18,469.275 16.561 9.684 4.8675 -
Global Peer INSULET CORPORATION NASDAQ 18,670.505 2,745.693 2,097.810 31.8990 -
Global Peer MASIMO CORPORATION NASDAQ 14,571.359 60.638 84.006 - -
Global Peer ABIOMED INC NASDAQ 14,682.711 65.105 65.105 11.0423 -
Other Global Peers DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), MICROPORT-100 (HKEx), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), ANGELALIGN (HKEx), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), HARTA (Bursa), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CARDIOFLOW-B (HKEx), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), VENUS MEDTECH-B (HKEx), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), PEIJIA-B (HKEx), CYTEK BIOSCIENCES INC (NASDAQ), LIFETECH SCI (HKEx), THE BEAUTY HEALTH COMPANY (NASDAQ), SUPERMX (Bursa), OUTSET MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ZYLOXTB-B (HKEx), INOVIO PHARMACEUTICALS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), KANGJI MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), AK MEDICAL (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), NANOSONICS LIMITED (ASX), LEMAITRE VASCULAR INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), VAREX IMAGING CORPORATION (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), BIOVENTUS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), 908 DEVICES INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CHUNLI MEDICAL (HKEx), MODERN DENTAL (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), KDL MEDICAL (HKEx), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), BASECARE-B (HKEx), ZYNEX INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NEUROPACE INC (NASDAQ), PAVMED INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), SOLITON INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), SIENTRA INC (NASDAQ), IRADIMED CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), MISONIX INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CVRX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), LUCIRA HEALTH INC (NASDAQ), YESTAR HEALTH (HKEx), NEURONETICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), QUOTIENT LTD (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), AROA BIOSURGERY LTD (ASX), UGHealthcare (SGX), PW MEDTECH (HKEx), CORMEDIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), TELA BIO INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), INTRICOM CORP (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SOMNOMED LIMITED (ASX), SURGALIGN HOLDINGS INC (NASDAQ), ALPHA PRO TECH (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), KELFRED (HKEx), FONAR CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), CHECK-CAP LTD (NASDAQ), MICRO-X LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), IRIDEX CORP (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ELECTROMED INC (NYSE American), NEUROMETRIX INC (NASDAQ), LENSAR INC (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), AVINGER INC (NASDAQ), OPTISCAN IMAGING (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), BIOLASE INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), ZOSANO PHARMA CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), SDI LTD (ASX), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ADVENTA (Bursa), ELECTROCORE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), YUNNAN ENERGY (HKEx), RGTBHD (Bursa), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RESONANCE HEALTH LTD (ASX), Biolidics (SGX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), COMPUMEDICS (ASX), STRATA SKIN SCIENCES INC (NASDAQ), CARDIEX LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), LKL (Bursa), DAXOR CORP (NYSE American), DIMERIX LTD (ASX), NANOVIBRONIX INC (NASDAQ), Yunnan Energy (SGX), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), DYNATRONICS CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), LBT INNOVATIONS LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), LIFE HEALTHCARE (HKEx), OVENTUS MEDICAL LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.840
-1.68 %
10 Days --6.870
-12.26 %
20 Days --35.070
-41.64 %
Medium Term Return 3 Months --45.880
-48.27 %
6 Months --41.480
-45.76 %
1 Year -+5.490
+12.57 %
Long Term Return 2 Years --34.750
-41.41 %
3 Years -+4.150
+9.22 %
5 Years -+15.930
+47.94 %
Annualised Return Annualised --
+8.15 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 40.075 - 99.000 Change From 1 Year Low +9.085 % Change From 1 Year Low (%) +22.67
Change From 1 Year High -49.840 % Change From 1 Year High (%) -50.34
2 Years Range 23.310 - 99.000 Change From 2 Years Low +25.850 % Change From 2 Years Low (%) +110.90
Change From 2 Years High -49.840 % Change From 2 Years High (%) -50.34
5 Years Range 23.075 - 99.000 Change From 5 Years Low +26.085 % Change From 5 Years Low (%) +113.04
Change From 5 Years High -49.840 % Change From 5 Years High (%) -50.34
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jul 2021 48.720 49.760 48.510 49.160 756,386 -
27 Jul 2021 47.820 48.545 46.320 48.200 738,143 -
26 Jul 2021 48.940 48.946 47.890 47.980 362,830 -
23 Jul 2021 49.890 50.395 48.880 49.920 309,314 -
22 Jul 2021 50.300 50.730 49.655 50.000 417,437 -
21 Jul 2021 48.000 49.720 46.710 49.720 1,453,596 -
20 Jul 2021 50.410 50.475 46.500 47.930 3,344,210 -
19 Jul 2021 56.390 57.520 55.500 56.310 699,841 -
16 Jul 2021 56.190 57.856 55.430 57.010 1,697,805 -
15 Jul 2021 57.210 57.210 54.052 56.030 2,056,839 -
14 Jul 2021 54.340 61.000 53.001 57.820 4,003,704 -
13 Jul 2021 76.030 76.640 73.500 73.570 358,835 -
12 Jul 2021 76.760 78.200 75.980 77.000 246,157 -
09 Jul 2021 77.930 77.930 74.120 76.470 700,420 -
08 Jul 2021 79.620 79.670 75.560 77.170 678,922 -
07 Jul 2021 82.700 84.100 79.880 81.080 192,595 -
06 Jul 2021 82.330 82.650 81.010 82.530 156,381 -
02 Jul 2021 84.320 84.810 81.710 82.450 206,356 -
01 Jul 2021 85.070 86.350 84.020 84.230 210,338 -
30 Jun 2021 82.210 84.920 81.760 84.830 569,436 -
29 Jun 2021 84.680 84.680 81.720 82.080 392,031 -
28 Jun 2021 86.530 86.615 84.150 84.390 233,690 -
Summary
Current 2 Weeks
(15 Jul 2021 to 28 Jul 2021)
57.210 57.856 46.320 49.160 11,836,401 -
Previous 2 Weeks
(30 Jun 2021 to 14 Jul 2021)
82.210 84.920 46.320 57.820 7,323,144 -
4 Weeks from
(02 Jun 2021 to 29 Jun 2021)
73.040 73.980 46.320 82.080 5,385,428 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.